Literature DB >> 9568464

Glutathione and HIV infection: reduced reduced, or increased oxidized?

F J Staal1.   

Abstract

Glutathione is the main intracellular defence against oxidative stress and regulates the cellular redox potential. HIV infection is accompanied by severe metabolic and immune dysfunctions. Several laboratories have demonstrated that the intracellular redox balance is disturbed in CD4+ T cells from HIV-seropositive subjects, which may potentiate HIV replication and partly explain the immunological abnormalities associated with HIV disease. The importance of glutathione for immune function, regulation of gene expression, as well as therapeutic interventions with redox-active drugs are discussed in this commentary.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9568464     DOI: 10.1046/j.1365-2362.1998.00268.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  13 in total

1.  Regulatory T cells interfere with glutathione metabolism in dendritic cells and T cells.

Authors:  Zhonghua Yan; Sanjay K Garg; Ruma Banerjee
Journal:  J Biol Chem       Date:  2010-10-30       Impact factor: 5.157

Review 2.  The glutathione system: a new drug target in neuroimmune disorders.

Authors:  Gerwyn Morris; George Anderson; Olivia Dean; Michael Berk; Piotr Galecki; Marta Martin-Subero; Michael Maes
Journal:  Mol Neurobiol       Date:  2014-04-22       Impact factor: 5.590

3.  HIV-Tat elicits microglial glutamate release: role of NAPDH oxidase and the cystine-glutamate antiporter.

Authors:  Sunita Gupta; Alecia G Knight; Shruti Gupta; Pamela E Knapp; Kurt F Hauser; Jeffrey N Keller; Annadora J Bruce-Keller
Journal:  Neurosci Lett       Date:  2010-09-19       Impact factor: 3.046

4.  Induction of cystine-glutamate transporter xc- by human immunodeficiency virus type 1 transactivator protein tat in retinal pigment epithelium.

Authors:  Christy C Bridges; Huankai Hu; Seiji Miyauchi; Umapathy N Siddaramappa; Malliga E Ganapathy; Leszek Ignatowicz; Dennis M Maddox; Sylvia B Smith; Vadivel Ganapathy
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-09       Impact factor: 4.799

Review 5.  Dual targeting of the thioredoxin and glutathione systems in cancer and HIV.

Authors:  Moran Benhar; Iart Luca Shytaj; Jonathan S Stamler; Andrea Savarino
Journal:  J Clin Invest       Date:  2016-05-02       Impact factor: 14.808

6.  Glutathione and adaptive immune responses against Mycobacterium tuberculosis infection in healthy and HIV infected individuals.

Authors:  Carlos Guerra; Devin Morris; Andrea Sipin; Steven Kung; Mesharee Franklin; Dennis Gray; Michelle Tanzil; Frederick Guilford; Fadi T Khasawneh; Vishwanath Venketaraman
Journal:  PLoS One       Date:  2011-12-02       Impact factor: 3.240

7.  Atherosclerosis: pathogenesis and increased occurrence in individuals with HIV and Mycobacterium tuberculosis infection.

Authors:  Timothy Guilford; Devin Morris; Dennis Gray; Vishwanath Venketaraman
Journal:  HIV AIDS (Auckl)       Date:  2010-10-29

8.  Glutathione synthesis is compromised in erythrocytes from individuals with HIV.

Authors:  Devin Morris; Judy Ly; Po-Ting Chi; John Daliva; Truongson Nguyen; Charleen Soofer; Yung C Chen; Minette Lagman; Vishwanath Venketaraman
Journal:  Front Pharmacol       Date:  2014-04-11       Impact factor: 5.810

9.  Aging is associated with increased regulatory T-cell function.

Authors:  Sanjay K Garg; Colin Delaney; Tomomi Toubai; Amiya Ghosh; Pavan Reddy; Ruma Banerjee; Raymond Yung
Journal:  Aging Cell       Date:  2014-02-25       Impact factor: 9.304

Review 10.  Glutathione: new roles in redox signaling for an old antioxidant.

Authors:  Katia Aquilano; Sara Baldelli; Maria R Ciriolo
Journal:  Front Pharmacol       Date:  2014-08-26       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.